the glocalized network in theragenomic and personalized medicine and the genetics of individual patients safety of drugs
December 23, 2014 – The U.S. Food and Drug Administration (FDA) just approved Saxenda (liraglutide [rDNA origin] injection) as a treatment option for chronic weight management in addition to a reduced-calorie diet and physical activity. The drug is approved for use …
The weight-management drug Liraglutide (Saxenda) has just been approved by the FDA Read more »
September 18, 2014 – We learn today from the U.S. Food and Drug Administration (FDA) of the approval of Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in adults with …
April 16, 2014 – The U.S. Food and Drug Administration (FDA) yesterday approved Tanzeum (albiglutide) subcutaneous injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Type 2 diabetes affects approximately 24 million people …
FDA approves Albiglutide [Tanzeum] to treat type 2 diabetes Read more »